S. Gavasso

发表

X-linked thrombophilia with a mutant factor IX (factor IX Padua).

V. Arruda, P. Simioni, D. Tormene, 2009, The New England journal of medicine.

Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome.

P. Simioni, D. Tormene, S. Gavasso, 2015, Clinica chimica acta; international journal of clinical chemistry.

Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study

P. Simioni, S. Gavasso, C. Bulato, 2021, Thrombosis Research.

Factor VIIa-antithrombin complexes in children with ischemic stroke.

P. Simioni, S. Gavasso, L. Spiezia, 2011, Thrombosis research.

Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis

P. Simioni, D. Tormene, S. Gavasso, 2010, Thrombosis and Haemostasis.

Peculiar laboratory phenotype/ genotype relationship due to compound inherited protein C defects in a child with severe venous thromboembolism.

P. Simioni, D. Tormene, S. Gavasso, 2018, Hamostaseologie.

Perioperative coagulation assessment of patients undergoing major elective orthopedic surgery

F. Biancari, P. Simioni, S. Gavasso, 2016, Internal and Emergency Medicine.

Increased anticoagulant response to low‐molecular‐weight heparin in plasma from patients with advanced cirrhosis

P. Simioni, M. Senzolo, S. Gavasso, 2012, Journal of thrombosis and haemostasis : JTH.

Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis.

M. Prins, P. Prandoni, P. Simioni, 2000, Blood.

Circulating microparticles in carriers of prothrombin G20210A mutation.

P. Simioni, S. Gavasso, L. Spiezia, 2014, Thrombosis and haemostasis.

Thrombin generation in Cushing’s Syndrome: do the conventional clotting indices tell the whole truth?

A. Frigo, C. Scaroni, P. Simioni, 2014, Pituitary.

Differential effects of high prothrombin levels on thrombin generation depending on the cause of the hyperprothrombinemia

J. Rosing, P. Simioni, D. Tormene, 2007, Journal of thrombosis and haemostasis : JTH.

Factor VIIa-antithrombin complexes plasma levels in cancer patients with and without thrombosis.

P. Simioni, S. Gavasso, L. Spiezia, 2012, Thrombosis research.

Incidence of Venous Thromboembolism in Families with Inherited Thrombophilia

M. Prins, H. Büller, J. T. ten Cate, 1999, Thrombosis and Haemostasis.

Thrombin generation in patients with COVID-19 with and without thromboprophylaxis

P. Navalesi, R. Vettor, P. Simioni, 2021, Clinical chemistry and laboratory medicine.

New Prothrombin Mutation (Arg596Trp, Prothrombin Padua 2) Associated With Venous Thromboembolism

P. Simioni, D. Tormene, S. Gavasso, 2016, Arteriosclerosis, thrombosis, and vascular biology.

Factor VIIa‐antithrombin complexes in patients with non‐neoplastic portal vein thrombosis with and without cirrhosis

P. Simioni, M. Senzolo, S. Gavasso, 2013, International journal of laboratory hematology.

Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis?

P. Simioni, M. Senzolo, S. Gavasso, 2014, Internal and Emergency Medicine.

are carriers of factor V Leiden: a prospective cohort study Incidence of venous thromboembolism in asymptomatic family members who

P. Prandoni, P. Simioni, A. Girolami, 2013 .

Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study.

P. Prandoni, P. Simioni, A. Girolami, 2002, Blood.

The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study

P. Prandoni, P. Simioni, D. Tormene, 2021, Internal and Emergency Medicine.

The haemostatic system in acromegaly: a single-centre case–control study

F. Ceccato, C. Scaroni, P. Simioni, 2020, Journal of Endocrinological Investigation.

Reversal of hypercoagulability in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals

P. Simioni, M. Senzolo, P. Burra, 2018, Liver international : official journal of the International Association for the Study of the Liver.

“In vitro” correction of the severe factor V deficiency‐related coagulopathy by a novel plasma‐derived factor V concentrate

P. Simioni, F. Peyvandi, G. Tagariello, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

congenital factor V deficiency Low plasma levels of tissue factor pathway inhibitor in patients with

J. Rosing, P. Simioni, S. Gavasso, 2013 .

Effect on Thrombin Generation of the “In Vitro” Addition of Low-Dose LMWH to Plasma of Healthy Pregnant and Nonpregnant Women

P. Simioni, S. Gavasso, L. Spiezia, 2012, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms.

J. Rosing, P. Simioni, S. Gavasso, 2010, Blood.

Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency.

J. Rosing, P. Simioni, S. Gavasso, 2008, Blood.

Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants.

P. Simioni, D. Tormene, G. Tognin, 2006, Thrombosis research.

Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study

P. Simioni, Anna Poretto, D. Tormene, 2020, Journal of the American Heart Association.

Failure of soluble fibrin polymers in the diagnosis of clinically suspected deep venous thrombosis.

P. Prandoni, A. Girolami, S. Gavasso, 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Dynamics of circulating microparticles in obesity after weight loss

R. Vettor, P. Simioni, L. Prevedello, 2016, Internal and Emergency Medicine.

Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S

P. Simioni, D. Tormene, S. Gavasso, 2015, Thrombosis and Haemostasis.

Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis

P. Prandoni, P. Simioni, D. Tormene, 2012, Thrombosis and Haemostasis.

The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort study

P. Prandoni, P. Simioni, S. Fortuna, 2005, Journal of thrombosis and haemostasis : JTH.

Alterations in the Coagulation Profile in Renal Pig‐to‐Monkey Xenotransplantation

G. Thiene, P. Simioni, D. Tormene, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

“Pseudo Homozygous” Activated Protein C Resistance due to Double Heterozygous Factor V Defects (Factor V Leiden Mutation and Type I Quantitative Factor V Defect) Associated with Thrombosis: Report of Two Cases Belonging to Two Unrelated Kindreds

P. Simioni, A. Girolami, P. Radossi, 1996, Thrombosis and Haemostasis.

Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutationRisk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis

M. Prins, P. Prandoni, P. Simioni, 2000 .

Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant

P. Simioni, A. Girolami, D. Tormene, 1998, British journal of haematology.

Factor IX activity/antigen ratio and the risk of first unprovoked venous thromboembolism.

P. Simioni, S. Gavasso, C. Bulato, 2013, Thrombosis and haemostasis.

Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19

P. Simioni, D. Tormene, S. Gavasso, 2022, Frontiers in Cell and Developmental Biology.

Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women

P. Simioni, Sonila Dhima, E. Cosmi, 2015, Scandinavian journal of clinical and laboratory investigation.

Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections

P. Angeli, P. Simioni, M. Senzolo, 2022, JHEP reports : innovation in hepatology.

More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC

F. Farinati, P. Simioni, M. Senzolo, 2021, Hepatology communications.

Influence of Hepatocellular Carcinoma on Platelet Aggregation in Cirrhosis

F. Farinati, P. Simioni, A. Vitale, 2021, Cancers.

Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis.

F. Farinati, P. Simioni, M. Senzolo, 2016, Thrombosis research.

Evaluation of a procoagulant phospholipid functional assay as a routine test for measuring circulating microparticle activity

P. Simioni, S. Gavasso, L. Spiezia, 2014, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Identification of a novel frameshift mutation causing a premature stop codon in a young Nigerian man with type I antithrombin deficiency.

P. Simioni, G. Tognin, S. Gavasso, 2013, Thrombosis research.

Prevalence of Antiphospholipid Antibodies and Lupus Anticoagulant in Juvenile Patients with Objectively Documented Deep-vein Thrombosis

A. Cogo, P. Simioni, A. Girolami, 1996 .

Prothrombin fragment 1+2 and thrombin–antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutation

P. Simioni, A. Girolami, B. Girolami, 1996, British journal of haematology.

Genetic modulation of the FVLeiden/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes

J. Rosing, P. Simioni, D. Tormene, 2012, Journal of thrombosis and haemostasis : JTH.

Endocytosis of exogenous factor V by ex‐vivo differentiated megakaryocytes from patients with severe parahaemophilia

P. Simioni, S. Gavasso, C. Bulato, 2016, British journal of haematology.

Long Term Use of Oral Contraceptives Without Thrombosis in Patients with FV Leiden Polymorphism: A Study of 37 Patients (2 Homozygous and 35 Heterozygous)

A. Girolami, B. Girolami, D. Tormene, 2004, Journal of Thrombosis and Thrombolysis.

Association between ABO blood group and bleeding phenotype in patients with mild rare bleeding disorders

P. Simioni, S. Gavasso, L. Spiezia, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Thrombosis and thrombophilia in children: a systematic review.

P. Simioni, D. Tormene, S. Gavasso, 2006, Seminars in thrombosis and hemostasis.

Severity of systemic inflammation is the main predictor of ACLF and bleeding in patients with acutely decompensated cirrhosis.

J. Trebicka, S. Zeuzem, F. Pelizzaro, 2022, Journal of hepatology.

Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death.

F. Farinati, P. Simioni, D. Tormene, 2022, Journal of hepatology.

Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute‐on‐chronic liver failure

P. Angeli, P. Simioni, D. Tormene, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo‐coagulable and Hyper‐coagulable Features

F. Wilson, P. Simioni, M. Ciarleglio, 2020, Hepatology.

In vitro and in vivo effects of the carbon monoxide‐releasing molecule, CORM‐3, in the xenogeneic pig‐to‐primate context

P. Simioni, R. Motterlini, S. Gavasso, 2009, Xenotransplantation.

Endothelial Damage of the Portal Vein is Associated with Heparin-Like Effect in Advanced Stages of Cirrhosis

P. Simioni, M. Senzolo, P. Burra, 2020, Thrombosis and Haemostasis.

1 Review The impact of obesity on hyperandrogen ism and polycystic ovary syndrome in premenopausal

H. Machado, P. Franchimont, A. Moreira, 1993 .

Reference values for thromboelastometry (ROTEM®) in cynomolgus monkeys (Macaca fascicularis).

P. Simioni, S. Gavasso, C. Bulato, 2010, Thrombosis research.

Comparable Levels of Activity and Antigen in Factor XII Deficiency: A Study of 21 Homozygotes and 58 Heterozygotes

A. Lombardi, A. Girolami, B. Girolami, 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

High prevalence of inherited thrombophilia in ‘presumed peri‐neonatal’ ischemic stroke

A. Suppiej, P. Simioni, P. Battistella, 2007, European Journal of Haematology.

Poster Presentations

E. Casiglia, F. Farinati, P. Simioni, 2014 .

Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study

P. Simioni, D. Tormene, S. Gavasso, 2022, Thrombosis and haemostasis.

Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease

M. Trauner, P. Ferenci, P. Simioni, 2020, Hepatology.

Premature ovarian failure: autoimmunity and natural history

S. Gavasso, C. Betterle, A. Caretto, 1993, Clinical endocrinology.

Contraceptive pills induce an improvement in congenital hypoplasminogenemia in two unrelated patients with ligneous conjunctivitis.

A. Girolami, S. Gavasso, L. Spiezia, 2003, Thrombosis and haemostasis.

The Occasional Venous Thromboses Seen in Patients with Severe (Homozygous) FXII Deficiency are Probably Due to Associated Risk Factors: A Study of Prevalence in 21 Patients and Review of the Literature

A. Lombardi, A. Girolami, S. Gavasso, 2004, Journal of Thrombosis and Thrombolysis.

Mutation analysis of hepcidin and ferroportin genes in Italian prospective blood donors with iron overload

M. Cappellini, P. Simioni, S. Gavasso, 2009, American journal of hematology.

Effects of Long-Term Administration of Recombinant Human Protein C in Xenografted Primates

M. Plebani, P. Simioni, S. Gavasso, 2011, Transplantation.

Effects of Long-term Administration of High-dose Recombinant Human Antithrombin in Immunosuppressed Primate Recipients of Porcine Xenografts

G. Thiene, M. Plebani, Y. Echelard, 2005, Transplantation.

Contraceptive pills induce an improvement in congenital hypoplasminogenemia in two unrelated patients with ligneous conjunctivitis

A. Girolami, S. Gavasso, L. Spiezia, 2003, Thrombosis and Haemostasis.

Thromboelastographic evaluation of coagulative profiles in pig‐to‐monkey kidney xenotransplantation

P. Simioni, S. Gavasso, C. Bulato, 2013, Xenotransplantation.

Thrombin activatable fibrinolysis inhibitor in cancer patients with and without venous thromboembolism.

P. Simioni, S. Gavasso, L. Spiezia, 2013, Thrombosis research.

Reply to “Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis”

P. Simioni, M. Senzolo, P. Burra, 2022, Platelets.

J. Rosing, P. Simioni, D. Tormene, 2010, Haematologica.

Combined Factor V and Factor VII Deficiency Due to an Independent Segregation of the Two Defects

A. Bertomoro, A. Girolami, E. Zanon, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Partial F8 gene duplication (Factor VIII Padua) associated with high factor VIII levels and familial thrombophilia.

L. Pagani, S. Cagnin, P. Simioni, 2020, Blood.

Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events

R. Vettor, P. Simioni, S. Gavasso, 2014, Thrombosis and Haemostasis.

Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.

P. Simioni, S. Gavasso, C. Bulato, 2011, Thrombosis research.

The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method

L. Punzi, P. Simioni, S. Gavasso, 2015, Clinical chemistry and laboratory medicine.

Platelet factor V levels in moderate to severe congenital factor V deficiency

G. Barillari, P. Simioni, G. Tognin, 2012, Haemophilia.

Determinants of increased thrombotic tendency in NASH cirrhosis: not there yet!

F. Farinati, P. Simioni, M. Senzolo, 2021, Transplant international : official journal of the European Society for Organ Transplantation.

In vitro and in vivo effects of the carbon monoxide‐releasing molecule, CORM‐3, in the xenogeneic pig‐to‐primate context

P. Simioni, R. Motterlini, S. Gavasso, 2009, Xenotransplantation.

Contact system and intrinsic pathway activation in patients with advanced pancreatic cancer: a prospective cohort study.

H. Büller, P. Simioni, A. Ilich, 2023, Journal of thrombosis and haemostasis : JTH.

Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency.

J. Rosing, P. Simioni, S. Gavasso, 2008, Blood.

Therapeutic Targets in Human Leukemia a Selective Sphingosine Kinase 1 Inhibitor Integrates Multiple Molecular

S. Gavasso, L. Spiezia, C. Radu, 2022 .

Profiling plasma alterations of extracellular vesicles in patients with acutely decompensated cirrhosis and bacterial infection

M. Senzolo, S. Gavasso, C. Radu, 2024, Liver international : official journal of the International Association for the Study of the Liver.

Reticulated platelets are increased and hyper-activated in patients with cirrhosis, especially those with poor outcome.

M. Senzolo, S. Gavasso, C. Radu, 2024, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Congenital Factor V Deficiency Low Plasma Levels of Tissue Factor Pathway Inhibitor in Patients With

E. Bouhassira, S. Gavasso, L. Spiezia, 2006 .